An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Posttraumatic stress disorder (PTSD) manifests after exposure to a traumatic event and is characterized by avoidance/numbing, intrusive symptoms and flashbacks, mood and cognitive disruptions, and hyperarousal/reactivity symptoms. These symptoms reflect dysregulation of the fear system likely caused by poor fear inhibition/extinction, increased generalization, and/or enhanced consolidation or acquisition of fear. These phenotypes can be modeled in animal subjects using Pavlovian fear conditioning, allowing investigation of the underlying neurobiology of normative and pathological fear. Pre-clinical studies reveal a number of neurotransmitter systems and circuits critical for aversive learning and memory, which have informed the development of therapies used in human clinical trials. In this review, we discuss the evidence for a number of established and emerging pharmacotherapies and device-based treatments for PTSD that have been developed via a bench to bedside translational model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.08.016 · Cited by 5,367 · cited 1×
“Additionally, transcranial magnetic stimulation shows promise for the treatment of psychiatric disorders, where noninvasive electrical current is delivered via a magnetic coil placed on the scalp (232).”
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 2×
“DBS is demonstrably efficacious for the treatment of Parkinson’s Disease, its original indication, and is now being investigated for the treatment of and depression, obsessive compulsive disorder (OCD), and PTSD (7, 222, 224-226).”
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval
Nader, K., Schafe, G. E., & Le Doux, J. E. (2000) · Nature · doi:10.1038/35021052 · Cited by 2,706 · cited 1×
“Reconsolidation involves transiently rendering memories labile through memory reactivation (200).”
The role of the amygdala in fear and anxiety
Davis, M. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.002033 · Cited by 2,357
THE AMYGDALA MODULATES THE CONSOLIDATION OF MEMORIES OF EMOTIONALLY AROUSING EXPERIENCES
McGaugh, J. L. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144157 · Cited by 2,296 · cited 1×
“Although numerous studies implicate NE, via β-adrenergic receptors, in consolidation of aversive memory (inhibitory avoidance learning, in particular), the role of NE in associative fear learning is less clear (179,187).”
Neurons in medial prefrontal cortex signal memory for fear extinction
Milad, M. R., & Quirk, G. J. (2002) · Nature · doi:10.1038/nature01138 · Cited by 1,836 · cited 1×
“These studies, along with evidence that tDCS of the dorsolateral prefrontal cortex modulates consolidation of cued fear, underline the importance of mPFC in fear learning, which has been extensively studied in rodents (6,236,237).”
Stress, memory and the amygdala
Roozendaal, B., McEwen, B. S., & Chattarji, S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2651 · Cited by 1,760 · cited 1×
“These studies suggest that glucocorticoid modulation enhances extinction memory, in line with preclinical evidence implicating the glucocorticoids in memory consolidation (119,120).”
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 2×
“Knockout or antagonism of Cnr1 increases anxiety-like behavior on a number of different paradigms across a variety of species (149,151,152).”
Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder
Milad, M. R., Pitman, R. K., Ellis, C. B., Gold, A. L., Shin, L. M., Lasko, N. B., Zeidan, M. A., Handwerger, K., Orr, S. P., & Rauch, S. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.026 · Cited by 1,339
LeDoux, J. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.005 · Cited by 1,281
Protective and damaging effects of stress mediators: central role of the brain
McEwen, B. S. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/bmcewen · Cited by 1,220 · cited 1×
“Chronic or extreme stress, however, can contribute to HPA axis dysregulation and a host of other adverse effects (77,78).”
Post-Traumatic Stress Disorder
Yehuda, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012941 · Cited by 1,134
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063 · cited 1×
“In humans, DCS shows promise for the treatment of social anxiety, obsessive compulsive disorder (OCD), panic disorder, acrophobia, and nicotine dependence (54-59).”
Self-citationPilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Foa, E. B., Hembree, E. A., Cahill, S. P., Rauch, S. A. M., Riggs, D. S., Feeny, N. C., & Yadin, E. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.5.953 · Cited by 931 · cited 1×
“Other studies report comparable or modest benefits with combinatorial treatment (36-42).”
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842 · cited 1×
“role in PTSD - receive serotonergic input via projections from the dorsal and median raphe nucleus (17-19).”
Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Self-citationVidal-Gonzalez, I., Vidal-Gonzalez, B., Rauch, S. L., & Quirk, G. J. (2006) · Learning & Memory · doi:10.1101/lm.306106 · Cited by 705 · cited 1×
“These studies, along with evidence that tDCS of the dorsolateral prefrontal cortex modulates consolidation of cued fear, underline the importance of mPFC in fear learning, which has been extensively studied in rodents (6,236,237).”
Glucocorticoids and the regulation of memory consolidation
Roozendaal, B. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00058-x · Cited by 665 · cited 1×
“These studies suggest that glucocorticoid modulation enhances extinction memory, in line with preclinical evidence implicating the glucocorticoids in memory consolidation (119,120).”
Dębiec, J., & Ledoux, J. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.018 · Cited by 602 · cited 3×
“Furthermore, propranolol administration significantly impairs auditory fear acquisition (whereas, treatment with an α1-adrenergic receptor antagonist facilitates fear acquisition) (195-197).”
Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 1×
“In humans, DCS shows promise for the treatment of social anxiety, obsessive compulsive disorder (OCD), panic disorder, acrophobia, and nicotine dependence (54-59).”
Stress-restress: Effects on ACTH and fast feedback
Liberzon, I., Krstov, M., & Young, E. A. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00044-9 · Cited by 556
The Influence of Stress Hormones on Fear Circuitry
Rodrigues, S. M., LeDoux, J. E., & Sapolsky, R. M. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135620 · Cited by 556
Brunet, A., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.006 · Cited by 548 · cited 1×
“Propranolol administration with trauma reactivation decreases physiological responses, such as heart rate and skin conductance, during subsequent mental imagery of the event (213).”
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.83 · Cited by 517
Presence and acquired origin of reduced recall for fear extinction in PTSD: Results of a twin study
Milad, M. R., Orr, S. P., Lasko, N. B., Chang, Y., Rauch, S. L., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.01.017 · Cited by 512
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510 · cited 1×
“Despite inconsistencies in the literature, meta-analyses suggest that DCS enhances fear extinction/exposure therapy in both animal and human subjects (69,70).”
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., & Marmar, C. R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00412-8 · Cited by 499
Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478 · cited 1×
“Somewhat consistent with rodent pre-clinical data, several studies indicate that outcomes for individuals treated with SSRIs and CBT outcomes may be worse compared to CBT alone (33-35).”
Campbell, D. G., Felker, B. L., Liu, C.-F., Yano, E. M., Kirchner, J. E., Chan, D., Rubenstein, L. V., & Chaney, E. F. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0101-4 · Cited by 458 · cited 1×
“Use of SSRIs in PTSD stems from the observed efficacy of SSRIs for depression and the high incidence of depression comorbid with anxiety and PTSD (8).”
Morphine use after combat injury in Iraq and post-traumatic stress disorder
Holbrook, T. L., Galarneau, M. R., Dye, J. L., Quinn, K., & Dougherty, A. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903326 · Cited by 429 · cited 2×
“Morphine has been shown to block fear acquisition in animals and is now being evaluated for secondary prevention of PTSD (126,127,143,144).”
Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415 · cited 1×
“Other studies report comparable or modest benefits with combinatorial treatment (36-42).”
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390 · cited 1×
“These data suggest that DCS may be an efficacious adjunctive therapy but only for a subset of the clinical population and with specifically tailored CBT sessions, among other factors (75,76).”
Self-citationNeumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., Potenza, M. N., Bailey, C. R., Lin, S. F., Najafzadeh, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.61 · Cited by 361 · cited 1×
“Furthermore, PET studies suggest that individuals with PTSD have increased brain Cnr1 availability, possibly due to changes in peripheral levels of the endocannabinoids (171-173).”
Brunet, A., Poundja, J., Tremblay, J., Bui, É., Thomas, É., Orr, S. P., Azzoug, A., Birmes, P., & Pitman, R. K. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318222f360 · Cited by 331
Gunduz-Cinar, O., MacPherson, K. P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., Godlewski, G., Ramikie, T. S., Gorka, A. X., Alapafuja, S. O., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.72 · Cited by 307
Zohar, J., Yahalom, H., Kozlovsky, N., Cwikel-Hamzany, S., Matar, M. A., Kaplan, Z., Yehuda, R., & Cohen, H. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.06.001 · Cited by 292 · cited 1×
“Hydrocortisone has also been shown to ameliorate PTSD symptoms when administered after extreme stress; however, a mechanism is still being determined (113).”
FAAH genetic variation enhances fronto-amygdala function in mouse and human
Dincheva, I., Drysdale, A. T., Hartley, C. A., Johnson, D. C., Jing, D., King, E. C., Ra, S., Gray, J. M., Yang, R., DeGruccio, A. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7395 · Cited by 289
Mueller, D., Porter, J. T., & Quirk, G. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3248-07.2008 · Cited by 284 · cited 1×
“Studies find evidence of noradrenergic activity in consolidation of associative fear learning and extinction (188-194).”
Fraser, G. A. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00071.x · Cited by 283
Xie, P., Kranzler, H. R., Poling, J., Stein, M. B., Anton, R. F., Brady, K., Weiss, R. D., Farrer, L., & Gelernter, J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.153 · Cited by 264
Hill, M. N., Bierer, L. M., Makotkine, I., Golier, J. A., Galea, S., McEwen, B. S., Hillard, C. J., & Yehuda, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.08.004 · Cited by 256
Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., & Pollack, M. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.036 · Cited by 251
VAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199808000-00007 · Cited by 250 · cited 1×
“Other studies report comparable or modest benefits with combinatorial treatment (36-42).”
Burghardt, N. S., Sullivan, G. M., McEwen, B. S., Gorman, J. M., & LeDoux, J. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.029 · Cited by 246
Lonergan, M. H., Olivera-Figueroa, L. A., Pitman, R. K., & Brunet, A. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120111 · Cited by 237 · cited 2×
“Propranolol shows some promise in improving PTSD symptoms by blocking reconsolidation processes (218), although these studies require replication.”
Yamamoto, S., Morinobu, S., Fuchikami, M., Kurata, A., Kozuru, T., & Yamawaki, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301605 · Cited by 224
de Kleine, R. A., Hendriks, G.-J., Kusters, W. J. C., Broekman, T. G., & van Minnen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.033 · Cited by 220
BERLAU, D., & MCGAUGH, J. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.12.008 · Cited by 220 · cited 1×
“Studies find evidence of noradrenergic activity in consolidation of associative fear learning and extinction (188-194).”
Foa, E. B., Franklin, M. E., & Moser, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01552-4 · Cited by 219 · cited 1×
“Other studies report comparable or modest benefits with combinatorial treatment (36-42).”
Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)
Ipser, J. C., & Stein, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001209 · Cited by 216 · cited 6×
“Somewhat consistent with rodent preclinical data, several studies indicate that outcomes for individuals treated with SSRIs and cognitive behavioral therapy (CBT) outcomes may be worse compared with CBT alone (33–35).”
InfluentialAdrenergic transmission facilitates extinction of conditional fear in mice
Cain, C. K., Blouin, A. M., & Barad, M. (2004) · Learning & Memory · doi:10.1101/lm.71504 · Cited by 215 · cited 1×
“Studies find evidence of noradrenergic activity in consolidation of associative fear learning and extinction (188-194).”
Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)
Hetrick, S. E., Purcell, R., Garner, B., & Parslow, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007316.pub2 · Cited by 212
Difede, J., Cukor, J., Wyka, K., Olden, M., Hoffman, H., Lee, F. S., & Altemus, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.317 · Cited by 212 · cited 1×
“For individuals with PTSD, DCS seems particularly effective when administered with virtual reality exposure (65,66).”
Maes, M., Lin, A., Bonacccorso, S., Van Hunsel, F., GASTEL, A. V., Delmeire, L., Biondi, M., Bosmans, E., Kenis, G., & Scharpé, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10092.x · Cited by 204
van Zuiden, M., Geuze, E., Willemen, H. L. D. M., Vermetten, E., Maas, M., Heijnen, C. J., & Kavelaars, A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050706 · Cited by 190 · cited 1×
“Prospective studies suggest that low cortisol in the face of trauma is a predisposing factor for the development of PTSD (87, 89-92).”
Burghardt, N. S., Bush, D. E. A., McEwen, B. S., & LeDoux, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.023 · Cited by 179 · cited 1×
“Several studies find increased cued fear acquisition and expression in rodents and humans with acute SSRI administration (24-26).”
Peña, D. F., Childs, J. E., Willett, S., Vital, A., McIntyre, C. K., & Kroener, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00327 · Cited by 165 · cited 1×
“A number of different stimulation tools— including DBS, vagus nerve stimulation, transcranial direct current stimulation (tDCS), and transcranial magnetic stimulation (TMS)—are under investigation and each are at various stages of development and testing at the preclinical and clinical levels (222,223).”
Cannabinoid facilitation of fear extinction memory recall in humans
Rabinak, C. A., Angstadt, M., Sripada, C. S., Abelson, J. L., Liberzon, I., Milad, M. R., & Phan, K. L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.063 · Cited by 163 · cited 1×
“Studies suggest delta-9-tetrahydrocannabinol (Δ9-THC) facilitates extinction of conditioned fear in healthy human volunteers (64,165).”
Grillon, C., Levenson, J., & Pine, D. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301204 · Cited by 162 · cited 1×
“Several studies find increased cued fear acquisition and expression in rodents and humans with acute SSRI administration (24-26).”
BLANCHARD, E. B., KOLB, L. C., PRINS, A., GATES, S., & McCOY, G. C. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199106000-00012 · Cited by 152
Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial
Haug, T. T., Blomhoff, S., Hellstrøm, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.4.312 · Cited by 151
Smits, J. A. J., Rosenfield, D., Otto, M. W., Powers, M. B., Hofmann, S. G., Telch, M. J., Pollack, M. H., & Tart, C. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.009 · Cited by 142 · cited 2×
“This is critical, as short exposure therapy sessions or sessions where individuals insufficiently inhibit fear can limit the effectiveness of adjunctive treatment or, worse, strengthen traumatic fear memory (73).”
Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139 · cited 1×
“behavior, where Cnr1 is thought to modulate glutamatergic and GABAergic signaling primarily in the bed nucleus of the stria terminalis, the basolateral amygdala, and the central amygdala (158-164).”
Limited efficacy of propranolol on the reconsolidation of fear memories
Muravieva, E. V., & Alberini, C. M. (2010) · Learning & Memory · doi:10.1101/lm.1794710 · Cited by 135 · cited 1×
“Notably, there are a number of negative trials across rodents and humans examining an effect of propranolol on reconsolidation (198,208,217).”
Woods, A. M., & Bouton, M. E. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.5.1159 · Cited by 133
Ganon-Elazar, E., & Akirav, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.204 · Cited by 120 · cited 1×
“behavior, where Cnr1 is thought to modulate glutamatergic and GABAergic signaling primarily in the bed nucleus of the stria terminalis, the basolateral amygdala, and the central amygdala (158-164).”
Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis
Rodrigues, H., Figueira, I., Lopes, A., Gonçalves, R., Mendlowicz, M. V., Coutinho, E. S. F., & Ventura, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093519 · Cited by 109 · cited 1×
“Despite inconsistencies in the literature, meta-analyses suggest that DCS enhances fear extinction/exposure therapy in both animal and human subjects (69,70).”
Hofmann, S. G. (2014) · Depression and Anxiety · doi:10.1002/da.22257 · Cited by 108
Guastella, A. J., Lovibond, P. F., Dadds, M. R., Mitchell, P., & Richardson, R. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.07.005 · Cited by 106 · cited 1×
“Other studies, have also not observe a reduction in conditioned fear with administration of DCS (62-64).”
Marin, M.-F., Camprodon, J. A., Dougherty, D. D., & Milad, M. R. (2014) · Depression and Anxiety · doi:10.1002/da.22252 · Cited by 106 · cited 2×
“development and testing at the pre-clinical and clinical level (222, 223).”
Bailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89
Yohimbine Enhancement of Exposure Therapy for Social Anxiety Disorder: A Randomized Controlled Trial
Smits, J. A. J., Rosenfield, D., Davis, M. L., Julian, K., Handelsman, P. R., Otto, M. W., Tuerk, P., Shiekh, M., Rosenfield, B., Hofmann, S. G., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.008 · Cited by 86 · cited 1×
“Individuals with social anxiety disorder and claustrophobia exhibit better outcomes when administered yohimbine in conjunction with exposure sessions, compared with outcomes in individuals administered placebo plus exposure (219,220).”
Effects of D-cycloserine on extinction of learned fear to an olfactory cue
Weber, M., Hart, J., & Richardson, R. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.12.010 · Cited by 83
Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans
Klumpers, F., Denys, D., Kenemans, J. L., Grillon, C., van der Aart, J., & Baas, J. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431624 · Cited by 72 · cited 1×
“Studies suggest delta-9-tetrahydrocannabinol (Δ9-THC) facilitates extinction of conditioned fear in healthy human volunteers (64,165).”
Van Apeldoorn, F. J., Van Hout, W. J. P. J., Mersch, P. P. A., Huisman, M., Slaap, B. R., Hale, W. W., Visser, S., Van Dyck, R., & Den Boer, J. A. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01157.x · Cited by 65 · cited 1×
“Other studies report comparable or modest benefits with combinatorial treatment (36-42).”
Deep brain stimulation of the ventral striatum increases BDNF in the fear extinction circuit
Do-Monte, F. H., Rodriguez-Romaguera, J., Rosas-Vidal, L. E., & Quirk, G. J. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00102 · Cited by 58 · cited 2×
“DBS of the ventral striatum that may be mediated by enhanced BDNF expression (53, 227, 228).”
Kuriyama, K., Honma, M., Soshi, T., Fujii, T., & Kim, Y. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2353-x · Cited by 54
Kuriyama, K., Honma, M., Yoshiike, T., & Kim, Y. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.045 · Cited by 36 · cited 1×
“Other studies, have also not observe a reduction in conditioned fear with administration of DCS (62-64).”
Cited by
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Krystal, J. H., Davis, L. L., Neylan, T. C., A. Raskind, M., Schnurr, P. P., Stein, M. B., Vessicchio, J., Shiner, B., Gleason, T. D., & Huang, G. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.007 · Cited by 265
“These medications are helpful but are believed to work via the same mechanism of action (12), and both produce reduction in symptom severity rather than remission of PTSD symptoms (13,14).”
BackgroundPerineuronal Nets in the Adult Sensory Cortex Are Necessary for Fear Learning
Banerjee, S. B., Gutzeit, V. A., Baman, J., Aoued, H. S., Doshi, N. K., Liu, R. C., & Ressler, K. J. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.007 · Cited by 163
Self-citationPrefrontal Cortex Stimulation Enhances Fear Extinction Memory in Humans
Raij, T., Nummenmaa, A., Marin, M.-F., Porter, D., Furtak, S., Setsompop, K., & Milad, M. R. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.022 · Cited by 156
Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino, T. F., Fitzgerald, P. J., & Maren, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.009 · Cited by 137
Metadata
- Authors
- Bowers, M. E., & Ressler, K. J.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 78
- Issue
- 5
- Pages
- E15-E27
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1480459594
- Cited by
- 145
- References
- 81
- FWCI
- 23.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.